spironolactone has been researched along with Shock, Cardiogenic in 8 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 75-year-old man with post-MI heart failure and an ejection fraction of 15 % was treated with an ACE-inhibitor, spironolactone and a beta-blocker." | 3.76 | [An elderly man with known heart failure admitted with cardiogenic shock]. ( Fagerheim, AK; Hardersen, R; Hovland, A; Nielsen, EW, 2010) |
| "Following a description of hemodynamic and metabolic effects of an acute myocardial infarction, indications for a therapy with furosemide, isosorbiddinitrate, digitalis, canrenoate-potassium, and dopamine and the results thereof are discussed." | 3.65 | [New aspects of treatment of hemodynamic complications in acute myocardial infarction (author's transl)]. ( Schröder, R, 1977) |
| "Shock is to define by clinical symptoms, measurable haemodynamic and metabolic changes, clotting failure and disorders of fluid, electrolyte and acid-base balance." | 1.26 | [Drug therapy of shock]. ( Bartels, O; Junge, O; Topf, G, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mody, KP | 1 |
| Lyons, JJ | 1 |
| Jorde, UP | 1 |
| Uriel, N | 1 |
| Hovland, A | 1 |
| Fagerheim, AK | 1 |
| Hardersen, R | 1 |
| Nielsen, EW | 1 |
| Schröder, R | 1 |
| Bartels, O | 2 |
| Junge, O | 1 |
| Topf, G | 1 |
| Lvoff, R | 1 |
| Wilcken, DE | 1 |
| Cohn, JN | 1 |
| Mathew, KJ | 1 |
| Franciosa, JA | 1 |
| Snow, JA | 1 |
| Ramdohr, B | 1 |
8 other studies available for spironolactone and Shock, Cardiogenic
| Article | Year |
|---|---|
A cold taken to heart.
Topics: Adenoviridae Infections; Adult; Biopsy; Cardiovascular Agents; Combined Modality Therapy; Defibrilla | 2015 |
[An elderly man with known heart failure admitted with cardiogenic shock].
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Ang | 2010 |
[New aspects of treatment of hemodynamic complications in acute myocardial infarction (author's transl)].
Topics: Animals; Canrenoic Acid; Digitalis Glycosides; Dogs; Dopamine; Furosemide; Hemodynamics; Humans; Myo | 1977 |
[Drug therapy of shock].
Topics: Bicarbonates; Dehydration; Dihydroergotoxine; Furosemide; Glucagon; Humans; Methylprednisolone; Peri | 1978 |
Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Body Weight; Digital | 1972 |
Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure.
Topics: Blood Pressure; Cardiac Output; Digoxin; Drug Evaluation; Ferricyanides; Furosemide; Heart Failure; | 1974 |
[Emergency therapy in manifested shock].
Topics: Acidosis; Adrenal Cortex Hormones; Bicarbonates; Capillary Permeability; Emergencies; Heart Massage; | 1973 |
Drug therapy in cardiogenic shock.
Topics: Cardiac Output; Digitalis Glycosides; Dopamine; Glucagon; Hemodynamics; Humans; Isoproterenol; Metap | 1973 |